# 2025-15157: Cambrex Charles City Applies to Manufacture Controlled Substances in Bulk

2025-15157, Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-08-11 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-15157
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-15157
- Title: Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 38665
- Published: 2025-08-11
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Cambrex Charles City Applies to Manufacture Controlled Substances in Bulk

## Summary

Cambrex Charles City wants to get official approval to make large amounts of certain controlled substances. This affects anyone involved in drug manufacturing and regulation, with no immediate cost or deadline changes announced. It’s a key step for them to legally produce these important chemicals.

## Abstract

Cambrex Charles City has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-15157 on federalregister.gov](https://www.federalregister.gov/documents/2025/08/11/2025-15157/bulk-manufacturer-of-controlled-substances-application-cambrex-charles-city)
- [2025-15157 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-08-11/pdf/2025-15157.pdf)

## Related
- [Previous: 2025-15156, Importer of Controlled Substances Application: Curia New York Inc](https://policyrisk.com/federal-register/2025-15156)
- [Next: 2025-15158, Importer of Controlled Substances Application: Benuvia Operations, LLC](https://policyrisk.com/federal-register/2025-15158)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-15157 (as of 2026-06-08).